Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 7, 2014; 20(37): 13239-13245
Published online Oct 7, 2014. doi: 10.3748/wjg.v20.i37.13239
Published online Oct 7, 2014. doi: 10.3748/wjg.v20.i37.13239
Enteral stents for the management of malignant colorectal obstruction
Jeremy Kaplan, Anna Strongin, Ali A Siddiqui, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19107, United States
Douglas G Adler, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, United States
Author contributions: Kaplan J, Strongin A, Adler DG and Siddiqui AA equally contributed to this work and wrote the manuscript.
Supported by (Entirely) Thomas Jefferson University Hospital and University of Utah through existing intramural funds and salary support
Correspondence to: Ali A Siddiqui, MD, Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Thomas Jefferson University Hospital, 132 S. 10th Street, Main Bldg Suite 585, Philadelphia, PA 19107, United States. ali.siddiqui@jefferson.edu
Telephone: +1-215-9550218 Fax: +1-215-9559555
Received: October 30, 2014
Revised: January 22, 2014
Accepted: June 12, 2014
Published online: October 7, 2014
Revised: January 22, 2014
Accepted: June 12, 2014
Published online: October 7, 2014
Core Tip
Core tip: Colonic stents are of benefit both as a bridge to surgery and as definitive therapy for colorectal obstruction in a large group of patients. Careful patient selection is required. Patients should be carefully managed in conjunction with the oncologist and surgeon. Endoscopists should also be vigilant for acute and delayed complications associated with colonic stent deployment.